Published in J Clin Microbiol on August 01, 2004
Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med (2013) 6.58
The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev (2010) 4.48
Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1. J Clin Microbiol (2008) 1.98
Toxinotype V Clostridium difficile in humans and food animals. Emerg Infect Dis (2008) 1.98
Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates. J Clin Microbiol (2006) 1.71
Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis (2010) 1.53
Diagnosis and treatment of acute or persistent diarrhea. Gastroenterology (2009) 1.35
Comparison of a rapid molecular method, the BD GeneOhm Cdiff assay, to the most frequently used laboratory tests for detection of toxin-producing Clostridium difficile in diarrheal feces. J Clin Microbiol (2009) 1.30
Community-acquired Clostridium difficile infection: an increasing public health threat. Infect Drug Resist (2014) 1.21
Asymptomatic Clostridium difficile colonisation and onward transmission. PLoS One (2013) 1.07
Community-associated Clostridium difficile infections, Monroe County, New York, USA. Emerg Infect Dis (2012) 1.01
Epidemiology of Clostridium difficile infection in two tertiary-care hospitals in Perth, Western Australia: a cross-sectional study. New Microbes New Infect (2014) 1.00
Diversity and Evolution in the Genome of Clostridium difficile. Clin Microbiol Rev (2015) 0.94
Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations. Open Forum Infect Dis (2014) 0.89
Characterization of cases of Clostridium difficile infection (CDI) presenting at an emergency room: molecular and clinical features differentiate community-onset hospital-associated and community-associated CDI in a tertiary care hospital. J Clin Microbiol (2011) 0.87
Frequent emergence of resistance in Clostridium difficile during treatment of C. difficile-associated diarrhea with fusidic acid. Antimicrob Agents Chemother (2006) 0.85
An agent-based simulation model for Clostridium difficile infection control. Med Decis Making (2014) 0.84
Parameters for the mathematical modelling of Clostridium difficile acquisition and transmission: a systematic review. PLoS One (2013) 0.83
Flooding and Clostridium difficile Infection: A Case-Crossover Analysis. Int J Environ Res Public Health (2015) 0.83
Mutations in fusA associated with posttherapy fusidic acid resistance in Clostridium difficile. Antimicrob Agents Chemother (2007) 0.82
Predictors of Clostridium difficile colitis infections in hospitals. Epidemiol Infect (2007) 0.82
Clinical features of Clostridium difficile infection and molecular characterization of the isolated strains in a cohort of Danish hospitalized patients. Eur J Clin Microbiol Infect Dis (2011) 0.82
Clinical update for the diagnosis and treatment of Clostridium difficile infection. World J Gastrointest Pharmacol Ther (2014) 0.81
Clostridium difficile infection, Colorado and the northwestern United States, 2007. Emerg Infect Dis (2012) 0.79
Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review. Infect Dis Ther (2016) 0.78
Prevalence and genotypic characteristics of Clostridium difficile in a closed and integrated human and swine population. Appl Environ Microbiol (2011) 0.78
Ribotyping of Clostridium difficile strains associated with nosocomial transmission and relapses in a Swedish County. APMIS (2012) 0.78
The incidence and clinical symptomatology of Clostridium difficile infections in a community setting in a cohort of Danish patients attending general practice. Eur J Clin Microbiol Infect Dis (2013) 0.77
Quantifying Transmission of Clostridium difficile within and outside Healthcare Settings. Emerg Infect Dis (2016) 0.75
Community- and Healthcare-Associated Clostridium difficile Infections, Finland, 2008-2013(1). Emerg Infect Dis (2016) 0.75
Determining Clostridium difficile intra-taxa diversity by mining multilocus sequence typing databases. BMC Microbiol (2017) 0.75
Probiotics for Clostridium difficile infection in adults (PICO): Study protocol for a double-blind, randomized controlled trial. Contemp Clin Trials (2015) 0.75
Nosocomial acquisition of Clostridium difficile infection. N Engl J Med (1989) 7.72
Clinical practice. Antibiotic-associated diarrhea. N Engl J Med (2002) 7.13
PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol (1999) 5.58
Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet (2001) 4.59
Clostridium difficile--associated diarrhea. Clin Infect Dis (1998) 4.06
Risk factors for Clostridium difficile infection. J Hosp Infect (1998) 3.81
Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis (1992) 3.37
Nosocomial Clostridium difficile colonisation and disease. Lancet (1990) 3.17
Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med (1999) 2.87
Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol (2000) 2.79
Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis (1997) 2.53
Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med (1994) 2.44
Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol (2000) 2.42
Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infect Control Hosp Epidemiol (1999) 2.40
Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis (1994) 2.29
Recurrence of symptoms in Clostridium difficile infection--relapse or reinfection? J Hosp Infect (1998) 2.00
Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J Infect Dis (1994) 1.96
Management and control of a large outbreak of diarrhoea due to Clostridium difficile. J Hosp Infect (1994) 1.91
Infection due to Clostridium difficile among elderly residents of a long-term-care facility. Clin Infect Dis (1993) 1.90
Survey of incidence of Clostridium difficile infection in Canadian hospitals and diagnostic approaches. J Clin Microbiol (1998) 1.89
A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clin Infect Dis (1998) 1.84
Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med (1996) 1.84
Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis (1993) 1.81
The epidemiology and typing of Clostridium difficile. J Antimicrob Chemother (1998) 1.59
Colonisation and transmission of Clostridium difficile in healthy individuals examined by PCR ribotyping and pulsed-field gel electrophoresis. J Med Microbiol (2001) 1.58
Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Am J Med (1990) 1.57
Clostridium difficile infection: responses, relapses and re-infections. J Hosp Infect (1992) 1.52
Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. Am J Gastroenterol (1985) 1.40
Typing of Clostridium difficile. Clin Microbiol Infect (2001) 1.37
Preliminary findings of the international typing study on Clostridium difficile. International Clostridium Difficile Study Group. Clin Infect Dis (1997) 1.37
Epidemiology of infectious and iatrogenic nosocomial diarrhea in a cohort of general medicine patients. Am J Infect Control (1995) 1.35
Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak. Infect Control Hosp Epidemiol (1991) 1.34
Genotyping of Clostridium difficile isolates. J Infect Dis (1994) 1.29
A sustained outbreak of Clostridium difficile in a general hospital: persistence of a toxigenic clone in four units. Infect Control Hosp Epidemiol (1994) 1.24
Molecular epidemiology of endemic Clostridium difficile infection. Epidemiol Infect (2001) 1.21
PCR ribotyping and arbitrarily primed PCR for typing strains of Clostridium difficile from a Polish maternity hospital. J Clin Microbiol (1995) 1.21
Low prevalence of nosocomial Clostridium difficile transmission, as determined by comparison of arbitrarily primed PCR and epidemiological data. J Hosp Infect (1999) 1.17
Increasing hospitalization and death possibly due to Clostridium difficile diarrheal disease. Emerg Infect Dis (1999) 1.16
Clostridium difficile diarrhea induced by cancer chemotherapy. Arch Intern Med (1992) 1.15
Diarrheal disease due to Clostridium difficile in general practice. Pathology (1991) 1.15
Molecular analysis of relapse vs re-infection in HIV-positive patients suffering from recurrent Clostridium difficile associated diarrhoea. J Hosp Infect (2001) 1.11
Antibiotics and Clostridium difficile diarrhea in the ambulatory care setting. Clin Ther (2000) 1.10
Wide diversity of Clostridium difficile types at a tertiary referral hospital. J Infect Dis (1994) 1.07
Risk factors for early recurrent Clostridium difficile-associated diarrhea. Clin Infect Dis (1998) 1.06
Community-acquired Clostridium difficile-associated diarrhea. Clin Infect Dis (1995) 1.05
Clostridium difficile-associated diarrhea: epidemiology, risk factors, and infection control. Infect Control Hosp Epidemiol (1997) 1.03
Clostridium difficile-associated diarrhea: epidemiological data from Western Australia associated with a modified antibiotic policy. Clin Infect Dis (2002) 1.01
Clostridium difficile infection in patients with haematological malignant disease. Risk factors, faecal toxins and pathogenic strains. Epidemiol Infect (1988) 0.98
Screening for carriage and nosocomial acquisition of Clostridium difficile by culture: a study of 284 admissions of elderly patients to six general hospitals in Wales. J Hosp Infect (1999) 0.97
Clostridium difficile-associated diarrhoea: epidemiological data from Western Australia. Epidemiol Infect (1994) 0.96
Role of antibody response in outcome of antibiotic-associated diarrhoea. Lancet (2001) 0.90
Isolation of various genotypes of Clostridium difficile from patients and the environment in an oncology ward. Clin Infect Dis (1997) 0.89
Clindamycin resistant strains of Clostridium difficile isolated from cases of C. difficile associated diarrhea (CDAD) in a hospital in Sweden. Diagn Microbiol Infect Dis (2002) 0.85
Clostridium difficile diarrhea after use of tacrolimus following renal transplantation. Clin Infect Dis (1998) 0.84
Drug risk factors associated with a sustained outbreak of Clostridium difficile diarrhea in a teaching hospital. Can J Infect Dis (1994) 0.82
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
The relation between survival and age at diagnosis in breast cancer. N Engl J Med (1986) 4.21
The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med (1989) 3.77
Parity, age at first childbirth, and risk of ovarian cancer. Lancet (1994) 3.48
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Apparent absence of transferable resistance to nalidixic acid in pathogenic Gram-negative bacteria. J Antimicrob Chemother (1977) 3.32
Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol (1997) 3.10
Protease-deficient mutants of Pseudomonas aeruginosa: pleiotropic changes in activity of other extracellular enzymes. J Gen Microbiol (1977) 2.59
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill (2008) 2.43
Resistance of Escherichia coli to penicillins. V. Physiological comparison of two isogenic strains, one with chromosomally and one with episomally mediated ampicillin resistance. J Bacteriol (1968) 2.27
Cancer risk in patients with diabetes mellitus. Cancer Causes Control (1991) 2.18
Ecological impact of ampicillin and cefuroxime in neonatal units. Lancet (1989) 2.11
Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol (1989) 2.07
Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer (1999) 1.98
Molecular model for elongation of the murein sacculus of Escherichia coli. Proc Natl Acad Sci U S A (1984) 1.97
Resistance of Escherichia coli to penicillins: fine-structure mapping and dominance of chromosomal beta-lactamase mutations. J Bacteriol (1977) 1.96
Colicin tolerance induced by ampicillin or mutation to ampicillin resistance in a strain of Escherichia coli K-12. J Bacteriol (1971) 1.96
Murein and the outer penetration barrier of Escherichia coli K-12, Proteus mirabilis, and Pseudomonas aeruginosa. J Bacteriol (1972) 1.95
Phage typing of Shigella sonnei. Arch Immunol Ther Exp (Warsz) (1968) 1.90
Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer (1998) 1.86
A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clin Infect Dis (1998) 1.84
Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. J Infect Dis (1991) 1.75
Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst (1999) 1.73
Evidence for diffuse growth of the cylindrical portion of the Escherichia coli murein sacculus. J Bacteriol (1983) 1.71
Evaluation of a ganglioside immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin. J Clin Microbiol (1979) 1.70
Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod (2006) 1.69
Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst (1997) 1.68
Autolysis of Neisseria gonorrhoeae. J Bacteriol (1976) 1.65
Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965-1983. Am J Epidemiol (1989) 1.62
Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control (2000) 1.61
Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids. Microbiology (1999) 1.61
Cigarette smoking, alcohol consumption, and risk of hip fracture in women. Arch Intern Med (2001) 1.59
Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe. Euro Surveill (2007) 1.55
A 10-year survey of clinically significant blood culture isolates and antibiotic susceptibilities from adult patients with hematological diseases at a major Swedish hospital. Scand J Infect Dis (1990) 1.53
Oral-contraceptive use and risk of hip fracture: a case-control study. Lancet (1999) 1.53
Resistance of Escherichia coli to penicillins. 8. Physiology of a class II ampicillin-resistant mutant. J Bacteriol (1970) 1.52
Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. J Pharmacol Exp Ther (1996) 1.51
Enterotoxigenic Escherichia coli and other gram-negative bacteria of infantile diarrhea: surface antigens, hemagglutinins, colonization factor antigen, and loss of enterotoxigenicity. J Infect Dis (1980) 1.51
Production of enzymes and toxins by hospital strains of Pseudomonas aeruginosa in relation to serotype and phage-typing pattern. J Med Microbiol (1973) 1.51
Risk of cancer in women receiving hormone replacement therapy. Int J Cancer (1989) 1.49
Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women. Epidemiology (1999) 1.49
Resistance of Escherichia coli to penicillins: identification of the structural gene for the chromosomal penicillinase. J Bacteriol (1973) 1.49
Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group. BMJ (1998) 1.48
Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up. Calcif Tissue Int (1993) 1.48
Dynamics of penicillin-susceptible clones in invasive pneumococcal disease. J Infect Dis (2001) 1.47
Delayed density-dependence in a small-rodent population. Proc Biol Sci (1995) 1.46
The effect of female sex hormones on cancer survival. A register-based study in patients younger than 20 years at diagnosis. JAMA (1990) 1.45
Correlation between surface and air counts of particles carrying aerobic bacteria in operating rooms with turbulent ventilation: an experimental study. J Hosp Infect (1999) 1.45
The HL-A7 histocompatibility antigen in sarcoidosis in relation to tuberculin sensitivity. Tissue Antigens (1975) 1.45
Long-term trends in incidence of and mortality from acute myocardial infarction and stroke in women: Analyses of total first events and of deaths in the Uppsala Health Care Region, Sweden. Epidemiology (1996) 1.45
Changes in the composition of Escherichia coli murein as it ages during exponential growth. J Bacteriol (1983) 1.43
An outbreak of listeriosis suspected to have been caused by rainbow trout. J Clin Microbiol (1997) 1.42
Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer (1997) 1.42
Use of oral contraceptives and endometrial cancer risk (Sweden). Cancer Causes Control (1999) 1.42
Predominance of staphylococcal cassette chromosome mec (SCCmec) type IV among methicillin-resistant Staphylococcus aureus (MRSA) in a Swedish county and presence of unknown SCCmec types with Panton-Valentine leukocidin genes. Clin Microbiol Infect (2005) 1.39
Relation between nursing procedures, other local characteristics and transmission of enteric bacteria in neonatal wards. J Hosp Infect (1993) 1.39
Biochemical fingerprinting compared with ribotyping and pulsed-field gel electrophoresis of DNA for epidemiological typing of enterococci. J Clin Microbiol (1995) 1.38
Mammographic parenchymal patterns in women receiving noncontraceptive estrogen treatment. Am J Epidemiol (1989) 1.38
Evidence for multisite growth of Escherichia coli murein involving concomitant endopeptidase and transpeptidase activities. J Bacteriol (1983) 1.38
Epidemiology of fecal strains of the family Enterobacteriaceae in 22 neonatal wards and influence of antibiotic policy. J Clin Microbiol (1988) 1.36
Cholecystectomy and colorectal cancer. Gastroenterology (1993) 1.35
Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int J Cancer (1997) 1.35
The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol (1992) 1.32
Seasonal fluctuations in the occurrence of enterotoxigenic bacteria and rotavirus in paediatric diarrhoea in Addis Ababa. Bull World Health Organ (1981) 1.27
A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: association with diminished debrisoquine hydroxylase activity. Br J Clin Pharmacol (1996) 1.26
Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin Endocrinol (Oxf) (1998) 1.26
Clonal analysis of Streptococcus pneumoniae nonsusceptible to penicillin at day-care centers with index cases, in a region with low incidence of resistance: emergence of an invasive type 35B clone among carriers. Microb Drug Resist (2003) 1.25
Collecting and banking human milk: to heat or not to heat? Br Med J (1980) 1.25
Time- and media-saving testing and identification of microorganisms by multipoint inoculation on undivided agar plates. J Clin Microbiol (1978) 1.25
Oral contraceptive use: interview data versus pharmacy records. Int J Epidemiol (1998) 1.23
Toxins, butyric acid, and other short-chain fatty acids are coordinately expressed and down-regulated by cysteine in Clostridium difficile. Infect Immun (2000) 1.23
Characterization of three Aeromonas and nine pseudomonas species by extracellular enzymes and haemolysins. Med Microbiol Immunol (1975) 1.22
Susceptibility of anaerobic bacteria to ALP 201. Antimicrob Agents Chemother (1989) 1.19
The role of obesity and weight fluctuations in the etiology of renal cell cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev (1994) 1.17
Alcoholism and cancer risk: a population-based cohort study. Cancer Causes Control (1992) 1.17
On the origin of branches in Escherichia coli. J Bacteriol (1999) 1.16
Prognostic characteristics in breast cancers after hormone replacement therapy. Breast Cancer Res Treat (1996) 1.16
What is the harm-benefit ratio of Cox-2 inhibitors? Int J Epidemiol (2008) 1.16
Demands on surgical inpatient services after mass mammographic screening. Br Med J (Clin Res Ed) (1986) 1.15
In vitro activity of DMG-Mino and DMG-DM Dot, two new glycylcyclines, against anaerobic bacteria. Eur J Clin Microbiol Infect Dis (1993) 1.15
Scleroderma and malignancy: an epidemiological study. Ann Rheum Dis (1993) 1.14
Estrogen receptor alpha gene polymorphisms and endometrial cancer risk. Carcinogenesis (2000) 1.13
Amplification of sex repressor function of one fi-+ R-factor during anaerobic growth of Escherichia coli. J Bacteriol (1975) 1.13
Risk of myocardial infarction after oophorectomy and hysterectomy. J Clin Epidemiol (2000) 1.12
An allelic variant of the chromosomal gene for class A beta-lactamase K2, specific for Klebsiella pneumoniae, is the ancestor of SHV-1. Antimicrob Agents Chemother (1997) 1.12
Treatment of hypertension with a new beta-blocking agent, pindolol (Visken). Eur J Clin Pharmacol (1973) 1.12
Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study. Ann Intern Med (1990) 1.12
In vitro susceptibility to 17 antimicrobials of clinical Clostridium difficile isolates collected in 1993-2007 in Sweden. Clin Microbiol Infect (2009) 1.12
The measurement of mood. Scand J Psychol (1979) 1.11
The aetiology and pathogenesis of human breast cancer. Mutat Res (1995) 1.11
Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia. Eur J Pediatr (1996) 1.10
Inhibition and restart of initiation of chromosome replication: effects on exponentially growing Escherichia coli cells. J Bacteriol (1995) 1.10
Breast cancer as a risk factor for other primary malignant diseases. A nationwide cohort study. J Natl Cancer Inst (1984) 1.08
Low-potency oestrogen and risk of endometrial cancer: a case-control study. Lancet (1999) 1.07
Detection of C polysaccharide in Streptococcus pneumoniae in the sputa of pneumonia patients by an enzyme-linked immunosorbent assay. J Clin Microbiol (1985) 1.07
Phage typing of Pseudomonas aeruginosa. Acta Pathol Microbiol Scand (1968) 1.07